Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-16-001531
Filing Date
2016-08-12
Accepted
2016-08-12 16:56:42
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nmus_10q.htm 10-Q 294595
2 CERTIFICATION nmus_ex311.htm EX-31.1 7712
3 CERTIFICATION nmus_ex312.htm EX-31.2 7576
4 CERTIFICATION nmus_ex321.htm EX-32.1 3104
5 CERTIFICATION nmus_ex322.htm EX-32.2 3116
  Complete submission text file 0001640334-16-001531.txt   2977556

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nmus-20160630.xml EX-101.INS 524220
7 XBRL TAXONOMY EXTENSION SCHEMA nmus-20160630.xsd EX-101.SCH 37447
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nmus-20160630_cal.xml EX-101.CAL 31445
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nmus-20160630_def.xml EX-101.DEF 144872
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nmus-20160630_lab.xml EX-101.LAB 318956
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nmus-20160630_pre.xml EX-101.PRE 217627
Mailing Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626
Business Address 650 TOWN CENTER DRIVE, SUITE 1770 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55136 | Film No.: 161828933
SIC: 2834 Pharmaceutical Preparations